Lamivudine (Page 6 of 6)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Lamivudine Tablets (HBV) 100 mg Label

Lamivudine Tablets (HBV) 100 mg Label
(click image for full-size original)
LAMIVUDINE lamivudine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0179-0172(NDC:31722-752)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LAMIVUDINE (LAMIVUDINE) LAMIVUDINE 100 mg
Inactive Ingredients
Ingredient Name Strength
CROSPOVIDONE
ISOMALT
ISOPROPYL ALCOHOL
MAGNESIUM STEARATE
METHYLENE CHLORIDE
HYPROMELLOSES
FERRIC OXIDE RED
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
TITANIUM DIOXIDE
FERRIC OXIDE YELLOW
Product Characteristics
Color pink Score no score
Shape CAPSULE (biconvex) Size 12mm
Flavor Imprint Code 37;I
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0179-0172-70 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203260 03/20/2015 02/28/2019
Labeler — KAISER FOUNDATION HOSPITALS (053052619)
Establishment
Name Address ID/FEI Operations
KAISER FOUNDATION HOSPITALS 053052619 repack (0179-0172)

Revised: 11/2018 KAISER FOUNDATION HOSPITALS

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.